References in periodicals archive ?
The use of galsulfase (Naglazyme) for Maroteaux-Lamy syndrome during pregnancy is under study by the Mucopolysaccharidosis VI (MPS VI) Clinical Surveillance Program (415-506-6849 or 415-506-6703)
After more tests, the bottom dropped out of Shahida's world when a consultant explained her wee boy was suffering from Maroteaux-Lamy syndrome, a progressive, genetic illness and was unlikely to live past childhood.
MPS VI, also known as Maroteaux-Lamy syndrome, is a life-threatening lysosomal storage disorder for which no specific drug treatments currently exist.